Oireachtas Joint and Select Committees
Wednesday, 12 July 2017
Joint Oireachtas Committee on Health
Evaluating Orphan Drugs: Discussion
9:00 am
Kate O'Connell (Dublin Bay South, Fine Gael) | Oireachtas source
Professor Barry referred to the complexity of the dossiers that the NCPE was receiving. Is there a set standard operating procedure by which companies submit information or does the NCPE just get a large box of stuff and has to root through it? If the approach is not streamlined, one can see how it might clog up the system.
Mr. Hennessy stated that some companies were not prepared to negotiate. Is that company specific or indication specific? Do some companies not play ball or do they view the Irish market as not being worth their while to reduce prices in respect of certain illnesses?
No comments